Keros Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC KROS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

186,779

Value ($000)

3,803

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,803	0.0%	186,779	12/31/2025
2025 Q3	11/10/2025	4,620	0.0%	292,006	9/30/2025
2025 Q2	8/12/2025	3,783	0.0%	283,403	6/30/2025
2025 Q1	9/15/2025	2,465	0.0%	241,923	3/31/2025
2024 Q4	2/6/2025	4,427	0.0%	279,682	12/31/2024
2024 Q3	11/12/2024	15,105	0.0%	260,120	9/30/2024
2024 Q2	8/12/2024	10,403	0.0%	227,628	6/30/2024
2024 Q1	5/9/2024	13,754	0.0%	207,758	3/31/2024
2023 Q4	2/6/2024	7,220	0.0%	181,578	12/31/2023
2023 Q3	11/8/2023	5,641	0.0%	176,953	9/30/2023
2023 Q2	8/10/2023	5,938	0.0%	147,785	6/30/2023
2023 Q1	5/12/2023	5,669	0.0%	132,768	3/31/2023
2022 Q4	2/13/2023	6,404	0.0%	133,352	12/31/2022
2022 Q3	11/14/2022	4,595	0.0%	122,116	9/30/2022
2022 Q2	8/15/2022	2,824	0.0%	102,175	6/30/2022
2022 Q1	5/13/2022	5,479	0.0%	100,740	3/31/2022
2021 Q4	2/11/2022	5,754	0.0%	98,336	12/31/2021
2021 Q3	11/16/2021	3,899	0.0%	98,544	9/30/2021
2021 Q2	8/16/2021	3,338	0.0%	78,584	6/30/2021
2021 Q1	5/17/2021	3,589	0.0%	58,310	3/31/2021
2020 Q4	2/16/2021	3,932	0.0%	55,733	12/31/2020
2020 Q3	11/13/2020	1,692	0.0%	43,849	9/30/2020
2020 Q2	8/20/2020	1,629	0.0%	43,407	6/30/2020